HeartSciences Inc.
HeartSciences Inc. (HSCS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · HSCS · as of Mar 31, 2024
Ownership Breakdown
23
Institutional Holders
▲ 4 vs Q4
$181,116
Total Inst. Value
▼ $22,293 vs Q4
2.17M
Shares Outstanding
freeFloat 90.59%
1.55M
13F Shares Held
▲ 351,065 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
HSCS largest shareholders · institutional ownership
Q1 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC orthopedic, prosthetic & surgical appliances & supplies | 191.5K | 35.61% | 35.61% | $22.39M | May 10, 2024 | ▲ 15.9K |
TRADITION WEALTH MANAGEMENT, LLC orthopedic, prosthetic & surgical appliances & supplies | 180.5K | 33.55% | 33.55% | $21.10M | May 13, 2024 | ▲ 12.3K |
NORTHERN TRUST CORP orthopedic, prosthetic & surgical appliances & supplies | 165.4K | 30.74% | 30.74% | $19.33M | May 14, 2024 | NEW |
CITADEL ADVISORS LLC orthopedic, prosthetic & surgical appliances & supplies | 123.1K | 22.88% | 22.88% | $14.39M | May 15, 2024 | ▲ 92.2K |
HRT FINANCIAL LP orthopedic, prosthetic & surgical appliances & supplies | 122.5K | 22.77% | 22.77% | $14.00M | May 13, 2024 | ▲ 122.5K |
HCR WEALTH ADVISORS orthopedic, prosthetic & surgical appliances & supplies | 100.0K | 18.59% | 18.59% | $11.69M | May 10, 2024 | NEW |
ASTORIA STRATEGIC WEALTH, INC. orthopedic, prosthetic & surgical appliances & supplies | 82.0K | 15.24% | 15.24% | $9.59M | May 7, 2024 | — held |
FIRST WESTERN TRUST BANK orthopedic, prosthetic & surgical appliances & supplies | 75.0K | 13.94% | 13.94% | $8.77M | May 16, 2024 | — held |
OLIVER LAGORE VANVALIN INVESTMENT GROUP orthopedic, prosthetic & surgical appliances & supplies | 70.4K | 13.08% | 13.08% | $8.22M | May 15, 2024 | ▼ 14.3K |
TOWER RESEARCH CAPITAL LLC (TRC) orthopedic, prosthetic & surgical appliances & supplies | 62.5K | 11.62% | 11.62% | $7.31M | May 15, 2024 | ▲ 50.2K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2024 vs prior quarter
Q1 2024
8
Increased
+321.5K shares6
New Positions
first time holders2
Decreased
−14.8K shares3
Sold Out
fully exitedNet shares change (top 50)
+306.6K
+321.5K / −14.8K
Net new holders
+9
6 new / 3 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
HSCS insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
2
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Wells David R. director | Jan 12, 2026 | Award | 15,000 | — | — | 15.0K | Form 4 ↗ |
Bent Bruce director | Jan 12, 2026 | Award | 15,000 | — | — | 15.0K | Form 4 ↗ |
HILZ MARK T See Remarks | Dec 22, 2025 | Award | 45,000 | — | — | 45.0K | Form 4 ↗ |
Szymczak Brian director | Dec 22, 2025 | Award | 15,000 | — | — | 15.0K | Form 4 ↗ |
Watson Danielle See Remarks | Dec 22, 2025 | Award | 15,000 | — | — | 15.0K | Form 4 ↗ |
Simpson Andrew See Remarks | Nov 28, 2025 | Award | 70,000 | $0.00 | $70 | 74.4K | Form 4 ↗ |
HILZ MARK T COO, Secretary and Director | Jul 29, 2025 | Sale | 4,416 | $3.54 | $15.6K | 4.8K | Form 4 ↗ |
Bent Bruce director | Jul 9, 2025 | Award | 25,000 | $4.37 | $109.3K | 25.0K | Form 4 ↗ |
Szymczak Brian director | Jul 9, 2025 | Award | 25,000 | $4.37 | $109.3K | 25.0K | Form 4 ↗ |
Simpson Andrew See Remarks | Jul 9, 2025 | Award | 275,000 | $4.37 | $1.20M | 275.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
HeartSciences Inc. (HSCS) is primarily owned by institutional investors, who hold approximately 71.8% of total shares outstanding. Company insiders own approximately 9.41%, while retail and public investors account for the remaining 18.84%.
The largest institutional shareholder of HeartSciences Inc. is VANGUARD GROUP INC, holding approximately 191,541 shares — equal to 35.61% of outstanding shares — as of March 31, 2024.
A total of 23 institutional investors currently hold HSCS stock, with a combined institutional value of approximately $181,116 as of the most recent 13F filing period.
Frequently asked questions
HSCS ownershipHeartSciences Inc. (HSCS) is primarily owned by institutional investors, who hold approximately 71.8% of shares. The largest shareholder is VANGUARD GROUP INC with a 35.61% stake. Company insiders hold 9.41%. Data sourced from SEC Form 13F as of March 31, 2024.